These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8433039)

  • 1. Inhibition of pseudohyphal growth as a neutrophil-mediated host defense mechanism against experimental deep Candida albicans infections in mice.
    Sohnle PG; Hahn BL
    J Lab Clin Med; 1993 Feb; 121(2):235-43. PubMed ID: 8433039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrays of Candida albicans pseudohyphae that protect the organisms from neutrophil fungicidal mechanisms in experimental infections of mice.
    Sohnle PG; Hahn BL; Wagner DK
    J Med Vet Mycol; 1994; 32(1):21-30. PubMed ID: 8207620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
    Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
    J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs.
    Sohnle PG; Frank MM; Kirkpatrick CH
    J Immunol; 1976 Aug; 117(2):523-30. PubMed ID: 781132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.
    Vonk AG; Netea MG; van Krieken JH; Iwakura Y; van der Meer JW; Kullberg BJ
    J Infect Dis; 2006 May; 193(10):1419-26. PubMed ID: 16619190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.
    Stuyt RJ; Netea MG; van Krieken JH; van der Meer JW; Kullberg BJ
    J Infect Dis; 2004 Apr; 189(8):1524-7. PubMed ID: 15073691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation by the new synthetic thiazole derivative tiprotimod. 3rd communication: influence on host resistance to microorganisms, tumors and on experimental immune disorders.
    Schorlemmer HU; Dickneite G; Hänel H; Dürckheimer W; Sedlacek HH
    Arzneimittelforschung; 1989 Oct; 39(10):1235-9. PubMed ID: 2692570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas-FasL interactions modulate host defense against systemic Candida albicans infection.
    Netea MG; van Der Meer JW; Meis JF; Kullberg BJ
    J Infect Dis; 1999 Nov; 180(5):1648-55. PubMed ID: 10515828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants.
    Sohnle PG; Collins-Lech C; Wiessner JH
    J Infect Dis; 1991 Jul; 164(1):137-42. PubMed ID: 2056200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of IL-18 and IL-12 in the host defense against disseminated Candida albicans infection.
    Netea MG; Vonk AG; van den Hoven M; Verschueren I; Joosten LA; van Krieken JH; van den Berg WB; Van der Meer JW; Kullberg BJ
    Eur J Immunol; 2003 Dec; 33(12):3409-17. PubMed ID: 14635050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid destruction of skeletal muscle fibers by mycelial growth forms of Candida albicans.
    Ashman RB; Fulurija A; Robertson TA; Papadimitriou JM
    Exp Mol Pathol; 1995 Apr; 62(2):109-17. PubMed ID: 8549694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.
    Huang W; Na L; Fidel PL; Schwarzenberger P
    J Infect Dis; 2004 Aug; 190(3):624-31. PubMed ID: 15243941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans.
    Basu S; Quilici C; Zhang HH; Grail D; Dunn AR
    Growth Factors; 2008 Feb; 26(1):23-34. PubMed ID: 18365876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro.
    Diamond RD; Krzesicki R; Jao W
    J Clin Invest; 1978 Feb; 61(2):349-59. PubMed ID: 340470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida -induced production of cytokines.
    Villamón E; Gozalbo D; Roig P; Murciano C; O'Connor JE; Fradelizi D; Gil ML
    Eur Cytokine Netw; 2004; 15(3):263-71. PubMed ID: 15542452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis.
    Zhang H; Chen H; Niu J; Wang Y; Xie L
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2653-9. PubMed ID: 19218608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice.
    Dimitrova P; Ivanovska N
    Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil death as a defence mechanism against Candida albicans infections.
    McNamara MP; Wiessner JH; Collins-Lech C; Hahn BL; Sohnle PG
    Lancet; 1988 Nov; 2(8621):1163-5. PubMed ID: 2903377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inefficiency of in vivo candidacidal mechanisms in experimental subcutaneous infections with Candida albicans in mice.
    Sohnle PG; Hahn BL; Radke L; Wagner DK
    Infect Immun; 1992 Sep; 60(9):3940-2. PubMed ID: 1500205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida albicans escapes from mouse neutrophils.
    Ermert D; Niemiec MJ; Röhm M; Glenthøj A; Borregaard N; Urban CF
    J Leukoc Biol; 2013 Aug; 94(2):223-36. PubMed ID: 23650619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.